Summary

The Home Infusion Therapy market accounted for USD 36.5 Billion in 2024 and is expected to reach USD 92.3 Billion by 2035, growing at a CAGR of around 8.8% between 2025 and 2035. The Home Infusion Therapy market is gradually expanding at a steady pace due to the rising inclination of healthcare practices toward home patient care and technological improvements in infusion therapies. As for using different treatments at home, it partially can be justified by the cultural and economic benefits, especially in cases with chronic diseases. Still, in its current state, you will have reimbursement issues, for instance, and also staff will be required to be specialized in handling such cases. With the implementation of telehealth and remote monitoring, patient adherence and safety have improved. To decrease hospital stays, home infusion therapy seems to be the solution. Therefore, constant innovation and the presentation of various strategies that involve different parties are fundamental in the formation of the market.
Rising Prevalence of Chronic Diseases
These diseases require long-term management since they are becoming more prevalent in today’s world and include diabetes, cancer, and immune diseases. This method of treatment is beneficial compared to hospital therapy it is comfortable and not less effective. Such settings are preferred since they are familiar to the patients, which would enhance compliance and subsequent results. This has prompted healthcare providers to start embracing and adopting home-based treatment regimes. This trend is simplifying the provision of home-based infusion services across the world. With the increase in diseases, people with chronic diseases need home infusion therapy.?
Limited Reimbursement Policies
Currently, an issue with reimbursement payment for home infusion therapy remains a great concern in many areas. These costs make it difficult for the patient to incur out-of-pocket charges, hence discouraging them from taking home treatment. It may also be disadvantageous to healthcare providers to offer these services with no remuneration, and therefore, they may avoid it. This can be a big issue financially, which in turn hinders the progression of home infusion therapy in developing nations. There is a need to increase standardization and extension of health care reimbursement policies for the development of this market. Unfortunately, without such measures, home infusion services continue to be inaccessible to most patients.?
Integration of Telehealth and Remote Monitoring
It has been noted that home infusion therapy has started being revolutionized by the introduction of telehealth solutions. Remote monitoring helps in that it enables the healthcare providers to monitor patients’ progress in real time. By so doing, it promotes timely interventions and helps in improving the overall quality of care. There are wonders on different fronts; patients are now receiving health care support they never required before or rarely visited the hospitals. This is why today, many individuals are shifting towards telehealth solutions in their home infusion services. They include more advancement in technology that will help in the further improvement of home-based treatments.?
Segment Analysis
The product types discussed in this study are infusion pumps, intravenous sets, IV cannulas, and needleless connectors. Infusion pumps, especially smart and ambulatory types, are common with flexibility and accuracy in the delivery of medication. The reduction of infection is another important aspect associated with the use of needleless connectors. The need for accessibility and usability of the products is pushing new development in this segment.?
The special applications comprise the anti-infective, endocrinal, infusion, hyper-hydration, oncology, nutritional support, and other special therapy medications. Oral anti-infectives, generally referred to as antibiotics, are usually prescribed to clients at home so that the infections can be controlled. The patients who receive chemotherapy prefer that way since it is comfortable and convenient for them. Home infusion therapy means that various medical conditions can be dealt with using home care services.
Regional Analysis
The home infusion therapy market in North America dominates due to high healthcare adoption and better reimbursement policies for home infusion therapy. The population is aged and has several underlying illnesses; hence, home care services are necessary. The availability of technology and a large number of representatives in the relevant market also contribute to the development of growth. Studies carried out indicate that there is constant evolution to develop more services in this area.?
Competitive Landscape
There is mid-range fragmentation in the global home infusion therapy market, with numerous stakeholders forming a competitive players' rivalry based on innovation, service differentiation, and location coverage. Multiple companies are now focusing on the development of advanced infusion devices and integration with other digital health solutions that will enable even the improvement of the delivery of care to the patients. Some of the trends involve joint endeavors with hospitals, pharmacies, and health agencies for home care services. Firms are also venturing into new markets to satisfy unsaturated markets out there. It was also established that customer service, delivery time, and compliance with various regulations formed the core strategic issues for competition.
Report Coverage:
By Product Type
- Infusion Pumps
- Elastomeric
- Electromechanical
- Gravity
- Others
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
- Drugs
By Application
- Anti-infective
- Endocrinology
- Diabetes
- Others
- Hydration Therapy
- Athletes
- Others
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
- Others
By Service Model
- Home Health Agencies
- Specialty Pharmacy Providers
- Telehealth Services
- Others

ページTOPに戻る

Table of Contents

1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Global Home Infusion Therapy Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Advancements in Infusion Technology
3.2.2. Rising prevalence of chronic diseases
3.2.3. Government initiatives and healthcare policies promoting home-based care and outpatient services
3.3. Key industry pitfalls & challenges
3.3.1. High Cost of Equipment and Medications
3.3.2. Risk of Complications
3.3.3. Need for trained nurses or caregivers to administer the therapy
3.4. Market Opportunities
3.4.1. Increasing healthcare infrastructure and rising health awareness in emerging markets
3.4.2. Integration with Digital Health
3.4.3. Increasing emphasis on preventive care and early intervention for chronic diseases
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Pipeline Analysis
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Home Infusion Therapy Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2023 & 2034
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Infusion Pumps
4.2.1. Market Size and Forecast, By 2024-2034 (USD Million)
4.2.2. Volumetric Pumps
4.2.2.1. Market Size and Forecast, By 2024-2034 (USD Million)
4.2.3. Syringe Pumps
4.2.3.1. Market Size and Forecast, By 2024-2034 (USD Million)
4.2.4. Ambulatory Pumps
4.2.4.1. Market Size and Forecast, By 2024-2034 (USD Million)
4.2.5. Elastomeric Pumps
4.2.5.1. Market Size and Forecast, By 2024-2034 (USD Million)
4.3. Intravenous (IV) Sets
4.3.1. Market Size and Forecast, By 2024-2034 (USD Million)
4.4. IV Cannulas
4.4.1. Market Size and Forecast, By 2024-2034 (USD Million)
4.5. Needle-less Connectors
4.5.1. Market Size and Forecast, By 2024-2034 (USD Million)
4.6. Other Consumables
4.6.1. Market Size and Forecast, By 2024-2034 (USD Million)
5. Home Infusion Therapy Market, Application Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Application, 2023 & 2034
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Anti-Infective Therapy
5.2.1. Market Size and Forecast, By 2024-2034 (USD Million)
5.3. Hydration Therapy
5.3.1. Market Size and Forecast, By 2024-2034(USD Million)
5.4. Chemotherapy
5.4.1. Market Size and Forecast, By 2024-2034 (USD Million)
5.5. Parenteral Nutrition
5.5.1. Market Size and Forecast, By 2024-2034 (USD Million)
5.6. Specialty Pharmaceuticals
5.6.1. Market Size and Forecast, By 2024-2034 (USD Million)
5.7. Pain Management
5.7.1. Market Size and Forecast, By 2024-2034 (USD Million)
5.8. Others
5.8.1. Market Size and Forecast, By 2024-2034 (USD Million)
6. Home Infusion Therapy Market, Route of Administration Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Technology, 2023 & 2034
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Intravenous (IV) Therapy
6.2.1. Market Size and Forecast, By 2024-2034 (USD Million)
6.3. Subcutaneous (SC) Therapy
6.3.1. Market Size and Forecast, By 2024-2034(USD Million)
6.4. Intramuscular (IM) Therapy
6.4.1. Market Size and Forecast, By 2024-2034 (USD Million)
6.5. Epidural
6.5.1. Market Size and Forecast, By 2024-2034 (USD Million)
7. Home Infusion Therapy Market, Patient Demographics Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By Patient Demographics, 2023 & 2034
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Pediatrics
7.2.1. Market Size and Forecast, By 2024-2034 (USD Million)
7.3. Adults
7.3.1. Market Size and Forecast, By 2024-2034(USD Million)
7.4. Geriatrics
7.4.1. Market Size and Forecast, By 2024-2034 (USD Million)
8. Home Infusion Therapy Market, Condition Type Segment Analysis
8.1. Overview
8.1.1. Market Revenue Share, By Condition Type, 2023 & 2034
8.1.2. Key Market Trends, Growth Factors, & Opportunities
8.2. Chronic Conditions
8.2.1. Market Size and Forecast, By 2024-2034 (USD Million)
8.3. Acute Conditions
8.3.1. Market Size and Forecast, By 2024-2034(USD Million)
9. Home Infusion Therapy Market, Indication Segment Analysis
9.1. Overview
9.1.1. Market Revenue Share, By Indication, 2023 & 2034
9.1.2. Key Market Trends, Growth Factors, & Opportunities
9.2. Cancer
9.2.1. Market Size and Forecast, By 2024-2034 (USD Million)
9.3. Gastrointestinal Diseases
9.3.1. Market Size and Forecast, By 2024-2034(USD Million)
9.4. Infectious Diseases
9.4.1. Market Size and Forecast, By 2024-2034 (USD Million)
9.5. Nutritional Deficiencies
9.5.1. Market Size and Forecast, By 2024-2034 (USD Million)
9.6. Immune Disorders
9.6.1. Market Size and Forecast, By 2024-2034 (USD Million)
9.7. Others
9.7.1. Market Size and Forecast, By 2024-2034 (USD Million)
10. Home Infusion Therapy Market, Region Segment Analysis
10.1. Overview
10.1.1. Global Market Revenue Share, By Region, 2023 & 2034
10.1.2. Global Market Revenue, By Region, 2024-2034 (USD Million)
10.2. North America
10.2.1. North America Market Revenue, By Country, 2024-2034 (USD Million)
10.2.2. North America Market Revenue, By Product Type, 2024-2034
10.2.3. North America Market Revenue, By Application, 2024-2034
10.2.4. North America Market Revenue, By Technology, 2024-2034
10.2.5. North America Market Revenue, By Patient Demographics, 2024-2034
10.2.6. North America Market Revenue, By Condition Type, 2024-2034
10.2.7. North America Market Revenue, By Indication, 2024-2034
10.2.8. U.S.
10.2.8.1. U.S. Market Revenue, By Product Type, 2024-2034
10.2.8.2. U.S. Market Revenue, By Application, 2024-2034
10.2.8.3. U.S. Market Revenue, By Technology, 2024-2034
10.2.8.4. U.S. Market Revenue, By Patient Demographics, 2024-2034
10.2.8.5. U.S. Market Revenue, By Condition Type, 2024-2034
10.2.8.6. U.S. Market Revenue, By Indication, 2024-2034
10.2.9. Canada
10.2.9.1. Canada Market Revenue, By Product Type, 2024-2034
10.2.9.2. Canada Market Revenue, By Application, 2024-2034
10.2.9.3. Canada Market Revenue, By Technology, 2024-2034
10.2.9.4. Canada Market Revenue, By Patient Demographics, 2024-2034
10.2.9.5. Canada Market Revenue, By Condition Type, 2024-2034
10.2.9.6. Canada Market Revenue, By Indication, 2024-2034
10.3. Europe
10.3.1. Europe Market Revenue, By Country, 2024-2034 (USD Million)
10.3.2. Europe Market Revenue, By Product Type, 2024-2034
10.3.3. Europe Market Revenue, By Application, 2024-2034
10.3.4. Europe Market Revenue, By Technology, 2024-2034
10.3.5. Europe Market Revenue, By Patient Demographics, 2024-2034
10.3.6. Europe Market Revenue, By Condition Type, 2024-2034
10.3.7. Europe Market Revenue, By Indication, 2024-2034
10.3.8. Germany
10.3.8.1. Germany Market Revenue, By Product Type, 2024-2034
10.3.8.2. Germany Market Revenue, By Application, 2024-2034
10.3.8.3. Germany Market Revenue, By Technology, 2024-2034
10.3.8.4. Germany Market Revenue, By Patient Demographics, 2024-2034
10.3.8.5. Germany Market Revenue, By Condition Type, 2024-2034
10.3.8.6. Germany Market Revenue, By Indication, 2024-2034
10.3.9. France
10.3.9.1. France Market Revenue, By Product Type, 2024-2034
10.3.9.2. France Market Revenue, By Application, 2024-2034
10.3.9.3. France Market Revenue, By Technology, 2024-2034
10.3.9.4. France Market Revenue, By Patient Demographics, 2024-2034
10.3.9.5. France Market Revenue, By Condition Type, 2024-2034
10.3.9.6. France Market Revenue, By Indication, 2024-2034
10.3.10. U.K.
10.3.10.1. U.K. Market Revenue, By Product Type, 2024-2034
10.3.10.2. U.K. Market Revenue, By Application, 2024-2034
10.3.10.3. U.K. Market Revenue, By Technology, 2024-2034
10.3.10.4. U.K. Market Revenue, By Patient Demographics, 2024-2034
10.3.10.5. U.K. Market Revenue, By Condition Type, 2024-2034
10.3.10.6. U.K. Market Revenue, By Indication, 2024-2034
10.3.11. Italy
10.3.11.1. Italy Market Revenue, By Product Type, 2024-2034
10.3.11.2. Italy Market Revenue, By Application, 2024-2034
10.3.11.3. Italy Market Revenue, By Technology, 2024-2034
10.3.11.4. Italy Market Revenue, By Patient Demographics, 2024-2034
10.3.11.5. Italy Market Revenue, By Condition Type, 2024-2034
10.3.11.6. Italy Market Revenue, By Indication, 2024-2034
10.3.12. Spain
10.3.12.1. Spain Market Revenue, By Product Type, 2024-2034
10.3.12.2. Spain Market Revenue, By Application, 2024-2034
10.3.12.3. Spain Market Revenue, By Technology, 2024-2034
10.3.12.4. Spain Market Revenue, By Patient Demographics, 2024-2034
10.3.12.5. Spain Market Revenue, By Condition Type, 2024-2034
10.3.12.6. Spain Market Revenue, By Indication, 2024-2034
10.3.13. Rest of Europe
10.3.13.1. Rest of Europe Market Revenue, By Product Type, 2024-2034
10.3.13.2. Rest of Europe Market Revenue, By Application, 2024-2034
10.3.13.3. Rest of Europe Market Revenue, By Technology, 2024-2034
10.3.13.4. Rest of Europe Market Revenue, By Patient Demographics, 2024-2034
10.3.13.5. Rest of Europe Market Revenue, By Condition Type, 2024-2034
10.3.13.6. Rest of Europe Market Revenue, By Indication, 2024-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Market Revenue, By Country, 2024-2034 (USD Million)
10.4.2. Asia Pacific Market Revenue, By Product Type, 2024-2034
10.4.3. Asia Pacific Market Revenue, By Application, 2024-2034
10.4.4. Asia Pacific Market Revenue, By Technology, 2024-2034
10.4.5. Asia Pacific Market Revenue, By Patient Demographics, 2024-2034
10.4.6. Asia Pacific Market Revenue, By Condition Type, 2024-2034
10.4.7. Asia Pacific Market Revenue, By Indication, 2024-2034
10.4.8. China
10.4.8.1. China Market Revenue, By Product Type, 2024-2034
10.4.8.2. China Market Revenue, By Application, 2024-2034
10.4.8.3. Canada Market Revenue, By Technology, 2024-2034
10.4.8.4. Canada Market Revenue, By Patient Demographics, 2024-2034
10.4.8.5. Canada Market Revenue, By Condition Type, 2024-2034
10.4.8.6. Canada Market Revenue, By Indication, 2024-2034
10.4.9. Japan
10.4.9.1. Japan Market Revenue, By Product Type, 2024-2034
10.4.9.2. Japan Market Revenue, By Application, 2024-2034
10.4.9.3. Japan Market Revenue, By Technology, 2024-2034
10.4.9.4. Japan Market Revenue, By Patient Demographics, 2024-2034
10.4.9.5. Japan Market Revenue, By Condition Type, 2024-2034
10.4.9.6. Japan Market Revenue, By Indication, 2024-2034
10.4.10. India
10.4.10.1. India Market Revenue, By Product Type, 2024-2034
10.4.10.2. India Market Revenue, By Application, 2024-2034
10.4.10.3. India Market Revenue, By Technology, 2024-2034
10.4.10.4. India Market Revenue, By Patient Demographics, 2024-2034
10.4.10.5. India Market Revenue, By Condition Type, 2024-2034
10.4.10.6. India Market Revenue, By Indication, 2024-2034
10.4.11. South Korea
10.4.11.1. South Korea Market Revenue, By Product Type, 2024-2034
10.4.11.2. South Korea Market Revenue, By Application, 2024-2034
10.4.11.3. South Korea Market Revenue, By Technology, 2024-2034
10.4.11.4. South Korea Market Revenue, By Patient Demographics, 2024-2034
10.4.11.5. South Korea Market Revenue, By Condition Type, 2024-2034
10.4.11.6. South Korea Market Revenue, By Indication, 2024-2034
10.4.12. Singapore
10.4.12.1. Singapore Market Revenue, By Product Type, 2024-2034
10.4.12.2. Singapore Market Revenue, By Application, 2024-2034
10.4.12.3. Singapore Market Revenue, By Technology, 2024-2034
10.4.12.4. Singapore Market Revenue, By Patient Demographics, 2024-2034
10.4.12.5. Singapore Market Revenue, By Condition Type, 2024-2034
10.4.12.6. Singapore Market Revenue, By Indication, 2024-2034
10.4.13. Rest of Asia Pacific
10.4.13.1. Rest of Asia Pacific Market Revenue, By Product Type, 2024-2034
10.4.13.2. Rest of Asia Pacific Market Revenue, By Application, 2024-2034
10.4.13.3. Rest of Asia Pacific Market Revenue, By Technology, 2024-2034
10.4.13.4. Rest of Asia Pacific Market Revenue, By Patient Demographics, 2024-2034
10.4.13.5. Rest of Asia Pacific Market Revenue, By Condition Type, 2024-2034
10.4.13.6. Rest of Asia Pacific Market Revenue, By Indication, 2024-2034
10.5. Latin America
10.5.1. Latin America Market Revenue, By Country, 2024-2034 (USD Million)
10.5.2. Latin America Market Revenue, By Product Type, 2024-2034
10.5.3. Latin America Market Revenue, By Application, 2024-2034
10.5.4. Latin America Market Revenue, By Technology, 2024-2034
10.5.5. Latin America Market Revenue, By Patient Demographics, 2024-2034
10.5.6. Latin America Market Revenue, By Condition Type, 2024-2034
10.5.7. Latin America Market Revenue, By Indication, 2024-2034
10.5.7.1. Brazil Market Revenue, By Product Type, 2024-2034
10.5.7.2. Brazil Market Revenue, By Application, 2024-2034
10.5.7.3. Brazil Market Revenue, By Technology, 2024-2034
10.5.7.4. Brazil Market Revenue, By Patient Demographics, 2024-2034
10.5.7.5. Brazil Market Revenue, By Condition Type, 2024-2034
10.5.7.6. Brazil a Market Revenue, By Indication, 2024-2034
10.5.8. Mexico
10.5.8.1. Mexico Market Revenue, By Product Type, 2024-2034
10.5.8.2. Mexico Market Revenue, By Application, 2024-2034
10.5.8.3. Mexico Market Revenue, By Technology, 2024-2034
10.5.8.4. Mexico Market Revenue, By Patient Demographics, 2024-2034
10.5.8.5. Mexico Market Revenue, By Condition Type, 2024-2034
10.5.8.6. Mexico a Market Revenue, By Indication, 2024-2034
10.5.9. Argentina
10.5.9.1. Argentina Market Revenue, By Product Type, 2024-2034
10.5.9.2. Argentina Market Revenue, By Application, 2024-2034
10.5.9.3. Argentina Market Revenue, By Technology, 2024-2034
10.5.9.4. Argentina Market Revenue, By Patient Demographics, 2024-2034
10.5.9.5. Argentina Market Revenue, By Condition Type, 2024-2034
10.5.9.6. Argentina Market Revenue, By Indication, 2024-2034
10.5.10. Rest of Latin America
10.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2024-2034
10.5.10.2. Rest of Latin America Market Revenue, By Application, 2024-2034
10.5.10.3. Rest of Latin America Market Revenue, By Technology, 2024-2034
10.5.10.4. Rest of Latin America Market Revenue, By Patient Demographics, 2024-2034
10.5.10.5. Rest of Latin America Market Revenue, By Condition Type, 2024-2034
10.5.10.6. Rest of Latin America Market Revenue, By Indication, 2024-2034
10.6. MEA
10.6.1. MEA Market Revenue, By Country, 2024-2034 (USD Million)
10.6.2. MEA Market Revenue, By Product Type, 2023– 2034
10.6.3. MEA Market Revenue, By Application, 2024-2034
10.6.4. MEA Market Revenue, By Technology, 2024-2034
10.6.5. MEA Market Revenue, By Patient Demographics, 2024-2034
10.6.6. MEA Market Revenue, By Condition Type, 2024-2034
10.6.7. MEA Market Revenue, By Indication, 2024-2034
10.6.8. GCC Countries
10.6.8.1. GCC Countries Market Revenue, By Product Type, 2023– 2034
10.6.8.2. GCC Countries Market Revenue, By Application, 2024-2034
10.6.8.3. GCC Countries Market Revenue, By Technology, 2024-2034
10.6.8.4. GCC Countries Market Revenue, By Patient Demographics, 2024-2034
10.6.8.5. GCC Countries Market Revenue, By Condition Type, 2024-2034
10.6.8.6. GCC Countries Market Revenue, By Indication, 2024-2034
10.6.9. South Africa
10.6.9.1. South Africa Market Revenue, By Product Type, 2023– 2034
10.6.9.2. South Africa Market Revenue, By Application, 2024-2034
10.6.9.3. South Africa Market Revenue, By Technology, 2024-2034
10.6.9.4. South Africa Market Revenue, By Patient Demographics, 2024-2034
10.6.9.5. South Africa Market Revenue, By Condition Type, 2024-2034
10.6.9.6. South Africa Market Revenue, By Indication, 2024-2034
10.6.10. Rest of Middle-East and Africa
10.6.10.1. Rest of Middle-East and Africa Market Revenue, By Product Type, 2023– 2034
10.6.10.2. Rest of Middle-East and Africa Market Revenue, By Application, 2024-2034
10.6.10.3. Rest of Middle-East and Africa Market Revenue, By Technology, 2024-2034
10.6.10.4. Rest of Middle-East and Africa Market Revenue, By Patient Demographics, 2024-2034
10.6.10.5. Rest of Middle-East and Africa Market Revenue, By Condition Type, 2024-2034
10.6.10.6. Rest of Middle-East and Africa Market Revenue, By Indication, 2024-2034
11. Company Profiles
11.1. Amerita Inc.
11.1.1. Business Overview
11.1.2. Financial Performance
11.1.3. Product/Service Offerings
11.1.4. Strategies & recent developments
11.1.5. SWOT Analysis
11.2. Amsino International, Inc.
11.2.1. Business Overview
11.2.2. Financial Performance
11.2.3. Product/Service Offerings
11.2.4. Strategies & recent developments
11.2.5. SWOT Analysis
11.3. B. Braun Melsungen AG
11.3.1. Business Overview
11.3.2. Financial Performance
11.3.3. Product/Service Offerings
11.3.4. Strategies & recent developments
11.3.5. SWOT Analysis
11.4. Baxter International Inc.
11.4.1. Business Overview
11.4.2. Financial Performance
11.4.3. Product/Service Offerings
11.4.4. Strategies & recent developments
11.4.5. SWOT Analysis
11.5. Becton Dickinson and Company
11.5.1. Business Overview
11.5.2. Financial Performance
11.5.3. Product/Service Offerings
11.5.4. Strategies & recent developments
11.5.5. SWOT Analysis
11.6. Contech Medical Systems Co. Ltd
11.6.1. Business Overview
11.6.2. Financial Performance
11.6.3. Product/Service Offerings
11.6.4. Strategies & recent developments
11.6.5. SWOT Analysis
11.7. Erenler Medikal
11.7.1. Business Overview
11.7.2. Financial Performance
11.7.3. Product/Service Offerings
11.7.4. Strategies & recent developments
11.7.5. SWOT Analysis
11.8. Fresenius Kabi
11.8.1. Business Overview
11.8.2. Financial Performance
11.8.3. Product/Service Offerings
11.8.4. Strategies & recent developments
11.8.5. SWOT Analysis
11.9. Halyard Health, Inc. (Avanos Medical)
11.9.1. Business Overview
11.9.2. Financial Performance
11.9.3. Product/Service Offerings
11.9.4. Strategies & recent developments
11.9.5. SWOT Analysis
11.10. ICU Medical Inc.
11.10.1. Business Overview
11.10.2. Financial Performance
11.10.3. Product/Service Offerings
11.10.4. Strategies & recent developments
11.10.5. SWOT Analysis
11.11. Lepu Medical Technology
11.11.1. Business Overview
11.11.2. Financial Performance
11.11.3. Product/Service Offerings
11.11.4. Strategies & recent developments
11.11.5. SWOT Analysis
11.12. Moog Inc.
11.12.1. Business Overview
11.12.2. Financial Performance
11.12.3. Product/Service Offerings
11.12.4. Strategies & recent developments
11.12.5. SWOT Analysis
11.13. JMS Co, Ltd.
11.13.1. Business Overview
11.13.2. Financial Performance
11.13.3. Product/Service Offerings
11.13.4. Strategies & recent developments
11.13.5. SWOT Analysis
11.14. Option Care Health, Inc.
11.14.1. Business Overview
11.14.2. Financial Performance
11.14.3. Product/Service Offerings
11.14.4. Strategies & recent developments
11.14.5. SWOT Analysis
11.15. Terumo Corporation, Inc.
11.15.1. Business Overview
11.15.2. Financial Performance
11.15.3. Product/Service Offerings
11.15.4. Strategies & recent developments
11.15.5. SWOT Analysis
11.16. Kroger
11.16.1. Business Overview
11.16.2. Financial Performance
11.16.3. Product/Service Offerings
11.16.4. Strategies & recent developments
11.16.5. SWOT Analysis
11.17. McKesson Corporation
11.17.1. Business Overview
11.17.2. Financial Performance
11.17.3. Product/Service Offerings
11.17.4. Strategies & recent developments
11.17.5. SWOT Analysis
11.18. InfuSystem Holdings, Inc.
11.18.1. Business Overview
11.18.2. Financial Performance
11.18.3. Product/Service Offerings
11.18.4. Strategies & recent developments
11.18.5. SWOT Analysis
11.19. KabaFusion
11.19.1. Business Overview
11.19.2. Financial Performance
11.19.3. Product/Service Offerings
11.19.4. Strategies & recent developments
11.19.5. SWOT Analysis
11.20. CareCentrix, Inc.
11.20.1. Business Overview
11.20.2. Financial Performance
11.20.3. Product/Service Offerings
11.20.4. Strategies & recent developments
11.20.5. SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1.GLOBAL HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 2.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 3.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 4.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 5.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 6.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 7.GLOBAL HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 8.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR CONSUMER ELECTRONICS, 2022-2028 (USD BILLION)
TABLE 9.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 10.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 11.GLOBAL HOME INFUSION THERAPY MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 12.NORTH AMERICA HOME INFUSION THERAPY MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 13.NORTH AMERICA HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 14.NORTH AMERICA HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 15.U.S HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 16.U.S HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 17.CANADA HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 18.CANADA HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 19.EUROPE HOME INFUSION THERAPY MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 20.EUROPE HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 21.EUROPE HOME INFUSION THERAPY MARKET VALUE, APPLICATION, 2022-2028 (USD BILLION)
TABLE 22.GERMANY HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 23.GERMANY HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 24.U.K HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 25.U.K HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 26.FRANCE HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 27.FRANCE HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 28.ITALY HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 29.ITALY HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 30.SPAIN SUPERCAPACITOR MATERIALS MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 31.SPAIN SUPERCAPACITOR MATERIALS MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 32.ROE HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 33.ROE HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 34.ASIA PACIFC HOME INFUSION THERAPY MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 35.ASIA PACIFC HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 36.ASIA PACIFC HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 37.CHINA HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 38.CHINA HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 39.INDIA HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 40.INDIA HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 41.JAPAN HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 42.JAPAN HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 43.REST OF APAC HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 44.REST OF APAC HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 45.REST OF WORLD HOME INFUSION THERAPY MARKET VALUE, BY PRODUCT TYPE, 2022-2028 (USD BILLION)
TABLE 46.REST OF WORLD HOME INFUSION THERAPY MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 47.CABOT(NORIT): FINANCIALS
TABLE 48.CABOT(NORIT): PRODUCTS & SERVICES
TABLE 49.CABOT(NORIT): RECENT DEVELOPMENTS
TABLE 50.KURARY CO. LTD: FINANCIALS
TABLE 51.KURARY CO. LTD: PRODUCTS & SERVICES
TABLE 52.KURARY CO. LTD: RECENT DEVELOPMENTS
TABLE 53.BAYER MATERIALSCIENCE AG: FINANCIALS
TABLE 54.BAYER MATERIALSCIENCE AG: PRODUCTS & SERVICES
TABLE 55.BAYER MATERIALSCIENCE AG: RECENT DEVELOPMENTS
TABLE 56.CALGON CARBON CORPORATION: FINANCIALS
TABLE 57.CALGON CARBON CORPORATION: PRODUCTS & SERVICES
TABLE 58.CALGON CARBON CORPORATION: RECENT DEVELOPMENTS
TABLE 59.CARBON NT&F: FINANCIALS
TABLE 60.CARBON NT&F: PRODUCTS & SERVICES
TABLE 61.CARBON NT&F: RECENT DEVELOPMENTS
TABLE 62.SHENZHEN NTP: FINANCIALS
TABLE 63.SHENZHEN NTP: PRODUCTS & SERVICES
TABLE 64.SHENZHEN NTP: RECENT DEVELOPMENTS
TABLE 65.CECA SA: FINANCIALS
TABLE 66.CECA SA: PRODUCTS & SERVICES
TABLE 67.CECA SA: RECENT DEVELOPMENTS
TABLE 68.CNANO TECHNOLOGY: FINANCIALS
TABLE 69.CNANO TECHNOLOGY: PRODUCTS & SERVICES
TABLE 70.CNANO TECHNOLOGY: RECENT DEVELOPMENTS
TABLE 71.DONAU CHEMIE GROUP: FINANCIALS
TABLE 72.DONAU CHEMIE GROUP: PRODUCTS & SERVICES
TABLE 73.DONAU CHEMIE GROUP: RECENT DEVELOPMENTS
TABLE 74.SHOWA DENKO: FINANCIALS
TABLE 75.SHOWA DENKO: PRODUCTS & SERVICES
SHOWA DENKO: RECENT DEVELOPMENTS